microRNA Profiles in Parkinson's Disease Prefrontal Cortex

Area of Science:

• Neuroscience
• Genetics
• Biomarker Discovery

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder with complex pathophysiology.
• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various diseases, including PD.

Purpose of the Study:

• To compare the miRNA profile of the frontal cortex in Parkinson's disease (PD) patients with that of normal controls.
• To identify PD-specific miRNA signatures.
• To investigate the relationship between miRNA levels and disease phenotypes such as age of onset and dementia.

Main Methods:

• Small RNA sequencing was performed on prefrontal cortex samples from 29 PD patients and 33 controls.
• Data underwent quality control, normalization, and batch correction.
• Linear regression identified differentially expressed miRNAs, and a classifier was built using weighted voting.
• Case-only analyses examined miRNA associations with age of onset and PD with dementia (PDD).

Main Results:

• 125 miRNAs were significantly differentially expressed in PD brains (FDR q < 0.05).
• A panel of 29 miRNAs accurately classified PD from non-diseased brains (96.6% sensitivity, 93.9% specificity).
• A pattern of miRNA alteration correlated with disease severity (control < PD without dementia < PDD).
• 36 miRNAs distinguished PDD from PD without dementia (81.2% sensitivity, 88.9% specificity).
• miR-10b-5p showed a positive association with age of onset in PD patients.

Conclusions:

• Cortical miRNA profiles can accurately classify PD brains.
• PDD exhibits a more pronounced miRNA alteration pattern compared to PD without dementia.
• Further research into brain-derived miRNA alterations in peripheral biofluids is needed to assess their clinical utility as biomarkers.